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Tuning Cellular Mechanics and Motility through Genetic Manipulation
of Rho GTPase and Myosin Activity
Joanna L. MacKay, Sanjay Kumar.
University of California, Berkeley, Berkeley, CA, USA.
The mechanical properties of cells such as size, shape, and stiffness have re-
cently been recognized as important regulators of cell behavior. For example,
cells cultured on small areas of extracellular matrix (ECM) grow slower than
cells on large areas (Chen et al., Science 1997), and cells confined to one-
dimensional lines elongate their bodies and migrate faster than cells cultured
on two-dimensional substrates (Doyle et al., JCB 2009). While there are
many strategies to indirectly control such behaviors through manipulation of
the ECM, there is a marked lack of strategies for controlling these behaviors
in more direct ways. To address this need, we have developed a genetic strategy
for directly tuning the mechanical properties of cells. Specifically, we have
placed genetic mutants of mechanotransductive proteins, including RhoA and
myosin light chain kinase (MLCK), under a conditional promoter and intro-
duced a single copy into glioblastoma cells using viral vectors. By expressing
these proteins from a conditional promoter, we can vary their expression by
simply changing the inducer concentration in the culture medium. RhoA and
MLCK are known to activate myosin II, which is the motor protein responsible
for force generation, and with constitutively active (CA) mutants of these pro-
teins, we can modulate cytoskeletal architecture, force generation, and cellular
stiffness in a graded fashion. Moreover, by switching expression of these pro-
teins on and off, we can dynamically control cell spreading, migration, and
ECM remodeling. We believe this strategy will serve as a valuable tool for
developing quantitative relationships between intracellular signaling, cellular
mechanics, and complex behaviors. Furthermore, such precise control over
cell behavior could allow us to dictate how cells physically interact with their
microenvironment, which would be particularly useful in tissue engineering
applications that interface cells with synthetic materials.
1920-Plat
Disruption of Myosin II Increases Axonal Elongation in Drosophila by
Accelerating Bulk Advance of the Growth Cone
Douglas H. Roossien1, Phillip Lamoureux1, Andrew N. George2,
David Van Vactor3, Kyle E. Miller1.
1Michigan State University, East Lansing, MI, USA, 2Duke University,
Durham, NC, USA, 3Harvard Medical School, Boston, MA, USA.
A pivotal question in cell biology is whether axons elongate by the assembly of
new material or bulk advance of the growth cone. While classic studies suggest
the former, recent work suggests forces drive translocation of the growth cone.
Here we ask three questions: Is the mechanism of growth cone advance con-
served between vertebrate and invertebrate neurons? How do growth cones ad-
vance in vivo? And, what is the role of myosin II force generation :in growth
cone motility? To address conservation, we analyzed the movement of organ-
elles and microtubules in neurons cultured from Drosophila embryos. We
found these moved in bulk as observed in chick sensory and Xenopus spinal
cord neurons. To assess transport in vivo, we co-expressed myr-td-tomato
and mito-GFP in stage 16 Drosophila embryos using the pan neuronal driver
elav. using time-lapse confocal microscopy to track the elongation of the
aCC pioneer motor axon in intact embryos, we also found bulk advance of
docked mitochondria. To better understand the role of myosin II in axonal elon-
gation, we cultured Drosophila neurons that were null for myosin II (Zipper)
and monitored bulk transport and growth cone motility. We found both rates
were significantly higher. using force calibrated towing needles, we found dis-
ruption of myosin II significantly decreased neuronal tension. Together, this
suggests axonal myosin II acts antagonistically against forces generated in
the growth cone to modulate translocation of the growth cone. This work has
important implications for the development of treatments for stroke, peripheral
nerve damage, and spinal cord injury.
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Qdot Labeled Actin Super-Resolution Motility Assay Measures Step-Size
for a Low Duty Cycle Muscle Myosin
Yihua Wang, Katalin Ajtai, Thomas P. Burghardt.
Mayo Clinic, Rochester, MN, USA.
Myosin powers contraction in heart and skeletal muscle and is a leading target
for mutations implicated in inheritable muscle diseases. During contraction,
myosin transduces ATP free energy into the work of muscle shortening against
resisting force. Muscle shortening involves the relative sliding of myosin and
actin filaments that is sometimes modeled in vitro with a motility assay quan-
titating actin filament translation over a myosin coated surface.
Skeletal actin filaments were fluorescence labeled with a streptavidin conjugate
quantum dot (Qdot) binding biotin-phalloidin on actin. Single Qdot’swere imaged in time as they translated with actin over the skeletal heavy
meromyosin (HMM) coated surface using total internal reflection fluorescence
microscopy. Qdots were spatially localized to a few nanometers using a super-
resolution algorithm and tracked over time. Average Qdot-actin velocity
matched measurements with rhodamine-phalloidin labeled actin. The Qdot-
actin velocity histogram contained low velocity events corresponding to actin
translation in quantized steps of ~5 nm. The quantization was independent of
myosin surface concentration.
Skeletal or cardiac myosin is a low duty cycle motor presenting challenges for
a single molecule assay because actomyosin dissociates quickly and the freely
moving element diffuses away. The in vitro motility assay enables modestly
more actomyosin interactions to sustain the complex while preserving a subset
of encounters that do not overlap in time on a single actin filament. A single
myosin step is isolated in time and space then characterized using super-
resolution. The approach opens the way for quick, quantitative, and inexpen-
sive step-size measurement in low duty cycle muscle myosins.This research
was supported by NIH Institutes: NIAMS R01 AR049277 and NHLBI
HL095572 and by the Mayo Foundation.
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Solving the Recalcitrant Crystal Structure of Group II Chaperonin
TRiC/CCT by Mass Spectrometry and Sentinel Correlation Analysis
Michael Levitt.
Stanford University, Stanford, CA, USA.
Eukaryotic group II Chaperonin TRiC or CCT is a 0.95 megadalton protein
complex that is essential for the correct and efficient folding of cytosolic poly-
peptides. The closed form is a 16 nm sphere made of two hemi-spherical rings
of 8 subunits (~550 residues/subunit) that rotate to open a central folding cham-
ber. In eukaryotes, 8 different genes encode the subunits of this ATP-powered
nanomachine. The high sequence identity of subunits made the 40,320 (=8 fac-
torial) possible arrangements indistinguishable in previous cryo-electron mi-
croscopy and crystallographic analysis.
First we use cross-linking, mass spectrometry and combinatorial homology
modeling. We react bovine TRiC under native conditions with a lysine-
specific cross-linker, follow up with trypsin digestion, and use mass spectrom-
etry to identify 63 cross-linked pairs providing distance restraints. Indepen-
dently of the cross-link set, we construct all 40,320 homology models of the
TRiC particle. When we compared each model with the cross-link set, we dis-
covered that one model is significantly more compatible than any other model.
Bootstrapping analysis confirms that this model is 10 times more likely to result
from this cross-link set than the next best-fitting model.
Second, we re-examine the 3.8 A˚ resolution X-ray data of yeast TRiC. Our
method of Sentinel Correlation Analysis (SCA) exhaustively tests all
2,580,460 possible models. This unbiased analysis singles out with overwhelm-
ing significance one model, which is fully consistent with our previous bio-
chemical data and refines to a much lower Rfree value than reported
previously with the same X-ray data. With four-fold averaging, our structure
reveals remarkably resolved details of the unique conformation of each subunit,
and suggests a mechanism for the initiation of transition to the open state. More
generally, we expect SCA to resolve ambiguity in future low-resolution crys-
tallographic studies.
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1Biochemistry, Brandeis University, Waltham, MA, USA, 2HHMI, Waltham,
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Understanding biological function, such as the fascinating rate acceleration of
enzymes, specificity of protein/protein interactions or the delicately controlled
action of signaling has been a long-standing challenge. Despite remarkable
information generated using chemical tools in the last 100 years, complemented
more recently with structural and computational approaches, we cannot yet
identify with a complete energy inventory how ANY protein works. The secret
of enzymes lies in their ability to partition energetic contributions among many
atoms in a well-coordinated style. To unravel these secrets, proteins in action
are spied on at atomic resolution to provide a comprehensive description of
enzyme catalysis in the form of an energy landscape. Since the rate of catalysis
is determined by the climb over a sequence of energy barriers, we focus here on
the critical question of transition pathways with the highest energy state being
the transition state.
I will discuss our exploration of the full energy landscape of enzyme catalysis
through a combination of time-resolved NMR including high-pressure NMR,
